The DoD Autism Clinical Trial Award, under the ARP, supports clinical trials aiming to impact the treatment or management of ASD. Projects must focus on human subjects and interventions like devices, drugs, or behavioral therapies. The grant does not fund preclinical research. Proposals need to have measurable outcomes and direct effects on human subjects. The closing date for applications is October 7, 2014.
Opportunity ID: 254351
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-14-ARP-CTA |
Funding Opportunity Title: | DoD Autism Clinical Trial Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 25, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | Oct 07, 2014 |
Current Closing Date for Applications: | Oct 07, 2014 |
Archive Date: | Nov 06, 2014 |
Estimated Total Program Funding: | $3,200,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@eBRAP.org
Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 254351 Full Announcement-1 -> arp_fy14 cta pa_gg.pdf
Packages
Agency Contact Information: | 301-682-5507; help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00195774 | Apr 25, 2014 | Oct 07, 2014 | View |
Package 1
Mandatory forms
254351 RR_SF424_2_0-2.0.pdf
254351 RR_Budget_1_3-1.3.pdf
254351 RR_KeyPersonExpanded_2_0-2.0.pdf
254351 PerformanceSite_2_0-2.0.pdf
Optional forms
254351 RR_SubawardBudget30_1_3-1.3.pdf